The marine biodiscovery pipeline and ocean medicines of tomorrow

Marcel Jaspars, Donatella De Pascale, Jeanette H. Andersen, Fernando Reyes, Alexander D. Crawford, Adrianna Ianora*

*Corresponding author for this work

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

Original languageEnglish
Pages (from-to)151-158
Number of pages8
JournalJournal of the Marine Biological Association of the United Kingdom
Volume96
Issue number1
Early online date19 Jan 2016
DOIs
Publication statusPublished - Feb 2016

Keywords

  • drug discovery
  • ocean medicines
  • PharmaSea project
  • natural-products
  • clinical-trials
  • pain
  • framework
  • systems
  • sponge

Cite this

The marine biodiscovery pipeline and ocean medicines of tomorrow. / Jaspars, Marcel; De Pascale, Donatella; Andersen, Jeanette H.; Reyes, Fernando; Crawford, Alexander D.; Ianora, Adrianna.

In: Journal of the Marine Biological Association of the United Kingdom, Vol. 96, No. 1, 02.2016, p. 151-158.

Research output: Contribution to journalArticle

Jaspars, Marcel ; De Pascale, Donatella ; Andersen, Jeanette H. ; Reyes, Fernando ; Crawford, Alexander D. ; Ianora, Adrianna. / The marine biodiscovery pipeline and ocean medicines of tomorrow. In: Journal of the Marine Biological Association of the United Kingdom. 2016 ; Vol. 96, No. 1. pp. 151-158.
@article{13e84acfcc114f53b41c6da48feda411,
title = "The marine biodiscovery pipeline and ocean medicines of tomorrow",
abstract = "Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.",
keywords = "drug discovery, ocean medicines, PharmaSea project, natural-products, clinical-trials, pain, framework, systems, sponge",
author = "Marcel Jaspars and {De Pascale}, Donatella and Andersen, {Jeanette H.} and Fernando Reyes and Crawford, {Alexander D.} and Adrianna Ianora",
year = "2016",
month = "2",
doi = "10.1017/S0025315415002106",
language = "English",
volume = "96",
pages = "151--158",
journal = "Journal of the Marine Biological Association of the United Kingdom",
issn = "0025-3154",
publisher = "Cambridge University Press",
number = "1",

}

TY - JOUR

T1 - The marine biodiscovery pipeline and ocean medicines of tomorrow

AU - Jaspars, Marcel

AU - De Pascale, Donatella

AU - Andersen, Jeanette H.

AU - Reyes, Fernando

AU - Crawford, Alexander D.

AU - Ianora, Adrianna

PY - 2016/2

Y1 - 2016/2

N2 - Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

AB - Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

KW - drug discovery

KW - ocean medicines

KW - PharmaSea project

KW - natural-products

KW - clinical-trials

KW - pain

KW - framework

KW - systems

KW - sponge

U2 - 10.1017/S0025315415002106

DO - 10.1017/S0025315415002106

M3 - Article

VL - 96

SP - 151

EP - 158

JO - Journal of the Marine Biological Association of the United Kingdom

JF - Journal of the Marine Biological Association of the United Kingdom

SN - 0025-3154

IS - 1

ER -